INDIA MARKET LENS

Aster DM Quality Care Limited (ASTERDM): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Aster DM Quality Care Limited, explained in plain English.

  • Aster DM Quality Care Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
  • ASTERDM closed at ₹741.75 on 18 November 2026.
  • Over the past year the shares are up 9.2%, trading between ₹519.10 and ₹891.30.
  • Our Pulse grade checklist scores it D (36/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
  • Annualised volatility over the past year is 29.37% with a maximum drawdown of -25.87% and a beta of 0.41 against NIFTY 50.
  • Recent coverage: Aster DM Quality Care Q2 net profit more than doubles to ₹262 crore
  • Recent coverage: Kotak adds 5 new midcap stocks which fell up to 16% in one month to its model portfolio. Take a look

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aurobindo Pharma, Biocon

Figures from the current session. Market open.

Aster DM Quality Care Limited (ASTERDM)

₹737.95

▼ 12.05 (-1.61%)

Price & volume

ASTERDM price chart, 1Y range. 252 points from 2025-11-19 to 2026-11-17. Opens at 662.6, closes at 737.95, ranging between 537.95 and 869.7.600700800Nov-25Jan-26Mar-26Apr-26Jun-26Aug-26Sep-26Nov-26volume

Hover for exact price & volume · green/red volume bars show up vs down days

Strong momentum · 4/5
✓ Above 50-day avg✓ Above 200-day avgRSI 57.7 · healthyMACD positiveBollinger %B 78ADX 24.7 · weak trend

1M

+9.43%

3M

-9.98%

6M

-2.08%

1Y

+8.67%

Where it sits in its 52-week range

60%
₹537.95₹869.7

Below 52-week high

15.1%

37.2% above the low

Momentum read

Strong

4/5 checks passed

52-wk high

₹869.7

52-wk low

₹537.95

Market cap

₹64,251 Cr

P/E (trailing)

93.9

Dividend yield

—

ROE

8.05%

Profit margin

7.23%

Revenue growth

136.3%

Price / Book

7.78

Debt / Equity

64.36

EPS (TTM)

7.86

Book value

₹94.84

Beta

0.41

Pulse grade: C, 56 out of 100

Momentum

B
  • ✓Trading above 50-day average
  • ✓Trading above 200-day average
  • ✓RSI in healthy 45-70 zone
  • ✕Positive 3-month return

Growth

A
  • ✓Revenue growth above Pharma & Healthcare median (20.8%)
  • ✓Revenue growing above 5%
  • ✓Quarterly profits trending up

Profitability

F
  • ✕Return on equity above Pharma & Healthcare median (14.56%)
  • ✕Return on equity above 12%
  • ✕Profit margin above Pharma & Healthcare median (13.82%)

Safety

D
  • ✕Debt below Pharma & Healthcare median (18.57)
  • ✓Debt not extreme for the sector
  • ✓Less volatile than the market (beta < 1.2)
  • ✕Pays a dividend

Quarterly revenue vs net profit

Revenue Net profit₹ crore, by quarter

Sep 2026: revenue ₹2,829 crore · net profit ₹262 crore · margin 9.3%

2,8290Jun 2025n/aSep 2025Dec 2025Mar 2026Jun 2026Sep 2026

Business quality

Intrinsic value

Building the model…

Analyst coverage

Who owns this company

Events, dividends & splits

Market position

Pharma & Healthcare sector

PeerPrice ₹Day changeFrom 52-wk high
SUNPHARMA1,870+0.13%-6.55%
DRREDDY1,388+0.73%0.00%
CIPLA1,388-0.47%-9.61%
DIVISLAB11,150+0.63%-3.59%
APOLLOHOSP8,712.5-0.67%-3.93%
LUPIN1,950-1.35%-22.46%

ASTERDM headlines

No ASTERDM stories right now.

ASTERDM filings & announcements

Reading the exchange…

ASTERDM, historical timeline

The timeline will be ready shortly

The rest of the page is unaffected.

Risk & return, last 12 months

Volatility (ann.)

29.37%

Sharpe ratio

0.3

Sortino ratio

0.44

Max drawdown

-25.87%

Daily VaR (95%)

-2.74%

CAGR (1Y)

11.42%

Return skew

0.23

Sharpe/Sortino use a 7% risk-free rate. VaR-95 = the daily loss exceeded only 5% of days last year.

Risk profile over time

Quant tearsheet

Monthly returns, how deep the falls ran, and how tightly it tracks NIFTY.